Concepedia

K-H Heider

KH

Statistics

Publications

7

Citations

594

H-Index

7

Active since

1993

Affiliations

Boehringer Ingelheim (Austria)(Current)

Boehringer Ingelheim (Germany)

University of Vienna

K-H Heider is an author at Boehringer Ingelheim (Austria) specializing in cd44 expression, medicine, and oncology.

Publications per year

1993–2017

7

Publications

7

CD44 variant exon epitopes in primary breast cancer and length of survival

M. Kaufmann, Gϋnter von Minckwitz, K-H Heider et al. · The Lancet · 1995 · 360 citations · Full text

, , +14

Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas

K-H Heider, Marlies Sproll, S. Susani et al. · Cancer Immunology Immunotherapy · 1996 · 83 citations

, , +14

Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858

Erika A. Eksioglu, X Chen, K-H Heider et al. · Leukemia · 2017 · 64 citations

, , +16

Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma.

N L Van Hal, Guus A.M.S. van Dongen, Carsten Brink et al. · PubMed · 1999 · 31 citations

, , +17

Expression of CD44 isoforms in human renal cell carcinomas

K-H Heider, Günther R. Adolf, Manfred Ratschek et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 1996 · 24 citations

, , +12

1–5 of 7